EUVIMEDEUVIMED entdecken
Crossref

Advancing Era and Rising Concerns in Nanotechnology-Based Cancer Treatment

Harshita Tiwari, Priyamvada Gupta, Ashish Verma, Swati Singh, Rajiv Kumar, Hemant Kumar Gautam, Vibhav Gautam

ACS Chemical Health & Safety · 25.03.2024 · 31 (2) · 153-161

DOI: 10.1021/acs.chas.3c00104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Health & Safety, online erschienen am 13.03.2024. Verfasst von Harshita Tiwari und 6 weiteren Autor:innen. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Banaras Hindu University, University Grants Commission, Science and Engineering Research Board.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is one of the most prevalent causes of mortality worldwide. The arena of cancer diagnosis and therapy has undergone a tremendous revolution since the development of nanotechnology. Due to their nanosize and biocompatibility, nanoparticles are extensively employed for gene therapy and targeted drug delivery. Nanotechnology-based approaches have also shown promising advancements in the utilization of extracellular vesicles for cancer diagnosis, prognosis, and therapy. Apart from this, the CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated protein 9)-based nanotherapy and the development of therapeutic nanovaccines have also demonstrated encouraging results in revolutionizing cancer treatment. Nanotechnology-based molecular imaging and contrast agents can detect cancer at very early stages, allowing for prompt treatment and better patient outcomes. Although nanoparticles offer multiple benefits for drug administration, they additionally possess certain pharmacokinetic limitations, such as body clearance, restricted tissue penetration, confrontation with biological barriers, biodistribution, and accumulation. However, improvements in nanoparticle design are intended to resolve safety issues and enhance the therapeutic effects of these particles in a variety of disease complications. While nanotechnology has demonstrated immense potential in the treatment and diagnosis of cancer, there are still several challenges to overcome, including guaranteeing the safety of nanomaterials, taking into account regulatory issues, and creating scalable and affordable solutions. Nevertheless, new developments in nanotechnology and current research hold promise for further revolutionizing cancer detection and treatment.

Förderung

  • Banaras Hindu University
  • University Grants Commission
  • Science and Engineering Research Board

Zitieren

APA

Tiwari, H., Gupta, P., Verma, A., Singh, S., Kumar, R., Gautam, H. K., & Gautam, V. (2024). Advancing Era and Rising Concerns in Nanotechnology-Based Cancer Treatment. ACS Chemical Health & Safety, 31(2), 153-161. https://doi.org/10.1021/acs.chas.3c00104

Vancouver

Tiwari H, Gupta P, Verma A, Singh S, Kumar R, Gautam HK, et al. Advancing Era and Rising Concerns in Nanotechnology-Based Cancer Treatment. ACS Chemical Health & Safety. 2024;31(2):153-161. doi:10.1021/acs.chas.3c00104

BibTeX
@article{Tiwari2024,
  author = {Tiwari, Harshita and Gupta, Priyamvada and Verma, Ashish and Singh, Swati and Kumar, Rajiv and Gautam, Hemant Kumar and Gautam, Vibhav},
  title = {Advancing Era and Rising Concerns in Nanotechnology-Based Cancer Treatment},
  journal = {ACS Chemical Health & Safety},
  year = {2024},
  volume = {31},
  number = {2},
  pages = {153--161},
  doi = {10.1021/acs.chas.3c00104}
}
Kostenlos starten →